TP53 and osteosarcoma: Previously a number of mouse strains were reported to develop osteosarcoma upon genetic manipulations, like TP53 germline mutation [83–85], osteoblast-restricted deletion of TP53 [86], overexpression of c-Fos [87–89], and heterozygous mutation of Nf2 [90, 91].